In the coming years the continuous peripheral nerve block catheter products market is expected to reach USD 659.2 million by 2025 and is expected to steadily grow at a CAGR of 6.1% to reach USD 1,191.8 million by 2035. In 2024, continuous peripheral nerve block catheter have generated roughly USD 621.3 million in revenues.
Continuous Peripheral Nerve Block Catheter (CPNB) is a device used for local, and sustained pain management of patients. It is used as local anesthetics by applying as specific peripheral nerves for an extended duration. This catheter is positioned near the relevant nerve or nerve bundles, with a permanent pump dispensing.
It finds its major application in postoperative pain relief, chronic pain relief, post-traumatic pain relief, and surgical or labor pain relief. Furthermore, constant and targeted pain management can provide much more uniform management with fewer side effects compared to systemic analgesics.
Use of this catheters into patients have witnessed faster recovery of patients, especially those undergoing arthroplasties or orthopedic procedures. Effective pain control tends to make them satisfied with the discharge, thus CPNB has become popular in contemporary management of pain.
From the years 2020 to 2024, the uptake of continuous peripheral nerve block catheter (CPNB) is attributed to a few past crucial events such as the COVID-19 pandemic. Pandemic inquisitively raised the need for alternatives to opioid pain management. Increased side effects caused by opioids led to an increase in demand for CPNB. Moreover, technological advances have made catheter placement safer, easier, and more accessible. Integration of ultrasound guidance further enhanced nerve identification and success rates of CPNB.
Furthermore, with the ideal patient recovery in mind, especially for elective surgeries, CPNB increase application focuses on the improvement of pain relief, speed of recovery, and rehabilitation. Alongside this trend, the increased interest in least invasive procedures has steered demand for regional anesthetic techniques and increased CPNB usage.
Explore FMI!
Book a free demo
Increased number of patients are averse to opioids in North America, and therefore, medical practitioners have been forced to seek alternatives for pain management, one of which is a regional anesthetic approach like the CPNB, which would be able to produce excellent pain relief without the connected risk of opioid addictive behavior.
With new technology, especially through the ultrasound, nerve block placement becomes safer and more accurate, paving the way for CPNB to be adopted as a proven and trusted technique. The push toward Enhanced Recovery After Surgery (ERAS) protocols, which minimize postoperative pain and speed recovery, has made the adoption of CPNB easier since it fits quite well with short hospital stays and mobilization.
CPNB provides targeted and sustained analgesia with minimal or no systemic drug adverse effects. It is the composite of all these that fuel the trend of acceptance of CPNB within the scope of today's pain management practice.
The acknowledgement of the great risk posed by opioid use has compelled medical systems to search for other alternatives for pain management. CPNB stands out as a safer and more successful alternative to managing postoperative and acute pain without the usage of opioids and their unwarranted side effects.
Fast-forward to the emergence of more recent technologies especially in ultrasound-guided techniques to allow for more effective and safer placements of nerve blocks thereby increasing overall success of CPNB. This allowed for a broader application of CPNB in surgical disciplines ranging from orthopedic to thoracic.
ERAS protocols in European healthcare systems have increasingly been directed towards strategies which aim for minimal opioid use, early recovery, and less postoperative pain. Lastly, almost all the successful clinical outcomes of CPNB in enhancing patient outcomes, decreasing complications, and facilitating faster recovery have accounted for its increasing use in European healthcare systems.
CPNB is emerging as one of those important methodological approaches for its specificity and efficacy, particularly with the improved infrastructure in healthcare. Since opioids are now a reality, it has been increasingly leading to an alternative movement toward safer non-opioid systems.
Human factors for clinicians to embrace CPNB in Asia with the abuse regulations of opioids are much more favorable and minimize dependence on opioids in post-operative and chronic pain. Ultrasound-guided nerve blocks have gradually developed into a much improved process, which became safer, more precise, and more convenient for operators to carry out. Also, increased health investment will create more improvement in access to quality medical services in emerging economies.
High-impact use of CPNB in Asia during the last few years is the result of growing emphasis on improved recovery after surgery (ERAS) programs, since it reduces pain, allows for early ambulation, and minimizes the length of stay after surgery. CPNB demand in the Asia Pacific market is being driven in great part by these factors.
Challenges
Technical Difficulties Associated with Catheter Placement Hindering Adoption in the Market
Ultrasound-Assisted CPNB technique helps with accuracy, improper catheter position may end up damaging the nerve, dislodging the catheter, or simply causing inadequate analgesia. In a few cases, patients may develop complications in the form of either infection at the site of catheter insertion or local anesthetic toxicity. Furthermore, the process requires trained clinicians with special expertise to place and confirm correct placement, which is limiting in trained professional health systems that are less accessible.
Continuous monitoring and management of the catheter will complicate care more so for patients with comorbidities. This increases resource requirements for implementing CPNB, hence limiting its acceptance in some environments or geographical areas where healthcare infrastructure is not great.
Opportunities
Growing Demand for Opioid-sparing Pain Management Solutions Poses New Business Opportunities for the Market Players
Among the most promising arenas for continuous peripheral nerve block catheter (CPNBs) lies the growing requirement for opioid-sparing pain management strategies. The opioid crisis, landscapes of which have developed mainly in North America and parts of Europe, has created a strong impetus for finding ways of treating pain that minimize opioid dependence and associated side effects.
CPNB provides an extremely localized method of pain management achieving long-term analgesia without opioid systemic side effects, making it ideal for postoperative pain management in joint replacement surgery, whereby opioid utilization has been historically very high.
Since healthcare systems are now laying a major focus on patient recovery and safety, the CPNB would elegantly fit under Enhanced Recovery After Surgery (ERAS) pathways in reducing narcotic consumption, improving recovery times, and shortening length of hospital stay.
Increase Success Rate and Safety with the use of Continuous Peripheral Nerve Block Catheter Anticipates its Market Growth
Continuous Peripheral Nerve Block Catheters utilizes cutting-edge ultrasound guidance in its application. It has been the CPNB that was most greatly improved in terms of the probability of success and safety of the procedure as a result of ultrasound-guided nerve localization. There was advanced nerve block given with a view toward precision and with fewer consequent complications like nerve injury or inadequate pain relief.
It will also include ultrasound guidance for real-time imaging while allowing the clinician to manipulate catheter placement accordingly. This, therefore, increased the confidence of healthcare practitioners to employ CPNB for daily procedures like orthopedic surgeries, trauma management, and postoperative pain management anticipates its future market growth.
Improved Post-surgical Recovery Rate Anticipates the Growth of the Market
The enhanced recovery after surgery protocols that hospitals and ambulatory surgery centers are adopting, CPNB catheters will become more and more prevalent. CPNB catheters are for continuous infusion of anesthetic near target nerves, and exist for the purpose of local pain relief after orthopedic, trauma, and abdominal procedures.
Opioid intake is reduced, risk of systemic side effects decreases, and length of hospitalization is shortened, and thus making CPNB catheters the preferred option for multimodal pain control approaches.
Growing Adoption of Continuous Peripheral Nerve Block Catheter in Ambulatory Care Clinics is Ongoing Trend in Market
Increasing use of continuous nerve blocks for ambulatory and home treatment is one of the prominent ongoing trend in the industry. With growing advancements in catheter technology, home infusion pumps, and patient education, there are increased efforts to see more and more patients using nerve block therapy from the comfort of their homes. Enhanced recovery after surgery (ERAS) protocols serve as the key driver, focusing on early discharge with subsequent self-management by the patients.
Provision of CPNB at home also minimizes the risk of hospital-acquired infection while optimizing recovery via rehabilitation and early mobility compared to inpatients. This is a more-remarked trend in North America and Europe where outpatient care and home health care services are becoming the increasingly prioritized area.
Emphasis of Manufacturers towards Development of Smart Catheters and Sensors Surges its Market Growth
Companies are designing intelligent catheters equipped with integrated sensors capable of monitoring infusion rates, identifying catheter migration, and allowing real-time information delivery to clinicians through associated platforms.
These innovations are capable not only of augmenting patient safety and pain management, but they also provide distance treatment and are very much appreciated in outpatient and home care settings. The transformation through technology is in line with the latest trend toward personalized, data-based healthcare.
From 2020 to 2024, the Continuous Peripheral Nerve Block (CPNB) catheter market grew steadily mainly due to demands for efficient postoperative pain relief and opioid-sparing strategies. The COVID-19 pandemic initially paused elective procedures and hence created impacts on demand, but as the surgical activities normalized, elective procedures resumed quickly.
The result was increased demand for CPNB catheters for regional pain relief, sparked by the growing trend toward Enhanced Recovery after Surgery (ERAS) programs in orthopedics, general, and trauma surgeries.
From future prospects i.e., during forecast period 2025 to 2035, the introduction of smart technologies such as sensor-tipped catheters and remote monitoring systems will enhance placement of catheters, adjust infusion rates for optimal delivery, and increase safety.
Growth will also come from the rising number of outpatient procedures and increased emphasis on home-pain management and pain relief alternatives to opioids. Product development will most likely push market growth with time, besides some of these factors, particularly in developed healthcare markets
| Category | 2020 to 2024 Trends |
|---|---|
| Regulatory Landscape | Regulatory agencies have put up a stricter provision on ensuring that Continuous Peripheral Nerve Block Catheters (CPNB) have safety and efficacy levels that are at the level of international medical standards such as FDA clearance and CE marking. Apart from this, devices are currently given most importance with respect to safety and quality, as well as appropriate training for healthcare professionals. |
| Technological Advancements | With the advances in ultrasound guidance and real-time monitoring systems, precision is enhanced further for the insertion of CPNB catheters and improving patient safety. Again, there is greater usage of portable infusion pumps, which promotes much better post-surgery rehabilitation. |
| Consumer Demand | Amidst the larger demand for CPNB, patient and clinician advocacy for organ-cultured pain management continues. Most of the urban populace, especially from the developed countries, has been the adopters of intravenous CPNB |
| Market Growth Drivers | The emergence of the CPNB market is propelled mainly by the factors such as the rise in the number of orthopedic procedures and joint replacement procedures undertaken, along with a growing focus on Enhanced Recovery After Surgery (ERAS) protocols. The opioid epidemic has also sped up the use of CPNB as an alternative mode of pain relief. |
| Sustainability | Manufacturers turn their attention to developing CPNB devices which would behighly energy-efficient, less invasive, and not too dependent on infrastructure while cuttingcosts of delivering care. Further focus widens to creating cost-effective and easily-accessible devices. |
| Category | 2025 to 2035 Projections |
|---|---|
| Regulatory Landscape | By 2035, the regulatory framework is expected to evolve with more robust global standards, especially in terms of device integration with digital health tools. Enhanced focus on patient safety, ethical application in pain management, and interoperability with other healthcare systems will shape the CPNB market |
| Technological Advancements | By 2035, CPNB technology will likely integrate AI-powered pain management systems, enabling more personalized, real-time adjustments to pain relief. Increased automation, remote monitoring, and home-use solutions will expand the scope of CPNB in both inpatient and outpatient settings. |
| Consumer Demand | By 2035, as the global focus on non-invasive, opioid-free pain management continues, the demand for CPNB will expand significantly. Its use will be increasingly prevalent in outpatient care and home-based settings, driven by patient preference for safer, long-lasting pain relief without systemic side effects. |
| Market Growth Drivers | The market will see significant expansion by 2035, driven by the growing aging population, increased surgical procedures, and a continuing trend toward opioid-sparing pain management. Personalized pain management approaches, supported by advancements in CPNB technologies, will be a key driver of future growth. |
| Sustainability | With an increase in the aging population, a growing number of surgical procedures, and a trending acceptance of other non-opioid alternatives for pain management, the market will experience extensive growth by 2035. Personalized pain management, along with continuing advancement of the technologies related to CPNB, will be a key driver in future growth. |
The opioid epidemic in the USA is one of the biggest catalysts prompting an increase in demand for Continuous Peripheral Nerve Block Catheters (CPNB). CPNB is now being increasingly used by practitioners to provide opioid-free pain relief, especially after surgeries in orthopedic replacement joint and trauma settings.
Moreover, there has been an increased overall movement toward patient-oriented care, with CPNB providing an undeniably stronger and more targeted form of pain management. The rising application of ambulatory and home CPNB solutions and the development of portable infusion pumps will continue to fuel growth in the next few years.
Market Growth Factors
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 3.8% |
Market Outlook
The increasing concern regarding enhanced recovery after surgery (ERAS) guidelines and the rise in minimally invasive surgeries in Germany have led to a proliferation of Continuous Peripheral Nerve Block Catheters (CPNB). CPNB is on the rise in Germany in a state with highly developed health care systems that increasingly resort to CPNB for postoperative pain management in orthopedic procedures.
The gentle and sustained approach among health care providers and regulatory agencies toward opioid-free pain management is a further propeller to the continuous peripheral nerve block (CPNB) through regional anesthesia methods. The future of CPNB in Germany is promising since ongoing advancements in ultrasound-guided catheter placement are expected to augment its uptake.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Germany | 4.1% |
Market Outlook
In India, the use of CPNB has largely been motivated by the increasing number of surgical procedures, particularly orthopedic surgeries, and a gradually increasing focus on minimally invasive surgery (MIS). CPNB is already considered a fairly valid alternative to opioid pain management as health infrastructure gets better- especially in a country where there is increasing concern regarding opioid abuse.
The escalating issues surrounding chronic pain and the growing geriatric population will be an additional driving factor in the necessitating secure, non-opioid pain management alternatives. Over time, the market will grow slowly as CPNB becomes more widely available in urban and rural areas.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| India | 5.7% |
The growing number of surgical procedures, including orthopedic and trauma surgeries, was closely associated with the fast growth of healthcare services in China over the last few years. The greater awareness that their government had about ways to reduce opioid usage because of health risks motivated the adoption of CPNB.
In addition, the regulations interested in minimizing surgical recovery periods also encourage using CPNB for managing postoperative pain under the ERAS protocols introduced by China. Future growth in the market for CPNB in China will be steered by technological improvements in ultrasound-guided nerve blocks.
Market Growth Drivers
| Country | CAGR (2025 to 2035) |
|---|---|
| China | 4.8% |
Increased usage Continues in Japan with the Continuous Peripheral Nerve Block Catheters (CPNB), so much so that the country is well endowed with the aging populace and the large number of orthopedic operations, such as hip or knee replacements. CPNB is used within the Japanese health system focusing on recovery time and quality of life making it applicable widely in postoperative pain treatment.
The further interest in minimally invasive techniques and opioid-free pain control has boosted the acceptance of such solutions like CPNB. The market shows much promise within Japan, especially with technology improvements enhancing catheter placement and efficacy.
Market Growth Drivers
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 5.2% |
The Non-Stimulating Catheters Segment Dominate the market owing to its Simple and Easier Use
Non-Stimulative Catheters make the leading segment in the CPNB market owing to their easier and quicker way to insert. since they do not depend on nerve stimulation for localization, making the procedure shorter and more effective. The introduction of ultrasound-guided techniques has also contributed immensely to non-stimulating catheter placements, making it almost as effective as using stimulating catheters, but without needing electric stimulation.
Non-stimulating catheters yield lesser discomfort to patients, hence improving the level of patient satisfaction. These are the reasons why such catheters are the most preferred for standard and simpler nerve blocks, adding to the supremacy in this market.
The Ability of Stimulating Catheters to provide precise nerve localization aid it hold Substantial Share
Stimulating Catheters will hold an important share in this segment mostly due to their specific capability to locate the nerve accurately. The electrical stimulation aspect lends itself to immediate feedback to know how close the catheter is to the nerve when it involves very complicated or deep nerve blocks such spinal and upper extremity nerve blocks. This makes stimulating catheters the number one choice for high-resolution procedures. Although these procedures take time to complete and are not comfortable for the patient, they have their important use where precision in pain management becomes paramount for the success of the procedure. The stimulating catheters will continue to take a large proportion in this regard, particularly for specialty procedures.
The Increasing use of Continuous Peripheral Nerve Block Catheters in Complex, High-volume Surgeries helps it lead the market
The hospital segment leads the Continuous Peripheral Nerve Block Catheter market since hospitals have a complex and large number of surgeries for highly equipped medical centers providing care for high-risk patients, making these hospitals suitable venues for major surgeries and trauma and orthopedic surgeries in which CPNB is extensively utilized.
The anesthesiologists working in these settings are well trained and are provided with sophisticated monitoring equipment that allows them to place CPNBs accurately. With the severity of postoperative pain management in these hospitals, CPNB is a major player in opioid-free pain management, thereby cementing its position in the hospital.
Increasing trend of Minimally Invasive Procedures aid Ambulatory Surgical Centers to grow at a Substantial Growth Rate
The demand for minimally invasive and outpatient methods is extending growth potential for the Ambulatory Surgical Center market. ASCs are considered better than the old hospital scenario with respect to cost savings, surgery, and recovery in one's own environment.
On the other hand, with the focus on Enhanced Recovery After Surgery (ERAS) pathways, CPNB finds acceptance among the ASCs for its ability to sustain effective local pain management without resorting to opioids, even more so in current times when there is a great need for pain control without opioid use. Further adding to the attractiveness of the space for ASCs would be the introduction of handheld infusion pumps allowing patient care at home after some procedures without compromising safety of the patients.
The continuous peripheral nerve block catheter (CPNB) market is going through tough competition among many competitive players in the field at present since there is escalating demand for safe and innovative non-opioid analgesic treatment solutions. These companies have developed improvements on catheters, ultrasound technology, and infusion pumps to enhance performance accuracy and safety for the patient.
Another area that is experiencing the fastest growth is providing solutions aimed at reducing complications associated with nerve block procedures. Therefore, smarter and safer devices are being developed. Furthermore, manufacturers are making cost-efficient solutions in order to satisfy users from both developed and emerging regions, rendering them affordable to most users.
The trends that continue to increase competition include the expansion of ambulatory surgery centers and growing outpatient services with companies at war to provide portable, easy-to-use, and effective systems that can be implemented across various clinical domains. Clinical alliances and regulatory approvals are also adding to the competitive advantage since they provide firms an avenue to fight for market share and credibility among healthcare providers.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| B. Braun Melsungen AG | 33.6% to 38.5% |
| Teleflex Incorporated | 20.4% to 22.6% |
| Halyard Health, Inc. | 50.1% to 17.2% |
| TELEFLEX MEDICAL | 4.6% to 6.8% |
| Other Companies (combined) | 12.1% to 15.4% |
| Company Name | Key Company Developments and Activities |
|---|---|
| B. Braun Melsungen AG | B. Braun brought out a newly launched CPNB system which is ultrasound-guided to better the process of carrying out nerve block procedures. They also advocated for ecological sustainability through the use of green packaging and energy-efficient parts within their lines of operation and also increased reach in outpatient services |
| Teleflex Incorporated | Teleflex has introduced a provocative CPNB catheter whose main use is improved localization of nerves to improve placement. The firm developed a range of options for opioid-free pain management and started looking at applications of home care for CPNB, meaning it can now stand alone in terms of outpatient use of the catheter |
| Halyard Health, Inc. | Their latest CPNB catheter is non-stimulating and applicable for minimal invasive procedures, thus enhancing patient comfort. Education and training of the health professions were championed to help spur the CPNB use in ambulatory surgical centers (ASCs) for post-operative pain management |
| TELEFLEX MEDICAL | TELEFLEX MEDICAL launched the CPNB system compatible with ultrasound, enhancing the accuracy and safety of performing such procedures. The company also extended its line to include portable infusion pumps for home use of CPNB aimed at complementing the rising need in the field for solutions regarding outpatient pain management |
Key Company Insights
Beyond the leading companies, several other manufacturers contribute significantly to the market, enhancing product diversity and technological advancements. They include:
These companies focus on expanding the reach of continuous peripheral nerve block catheter, offering competitive pricing and cutting-edge innovations to meet diverse needs.
The overall market size for continuous peripheral nerve block catheter market was USD 659.2 million in 2025.
The continuous peripheral nerve block catheter market is expected to reach USD 1,191.8 million in 2035.
Increase in adoption of continuous peripheral nerve block catheter as an alternative to opiod analgesics anticipates the growth of the market.
The top key players that drives the development of continuous peripheral nerve block catheter market are B. Braun Melsungen AG, Teleflex Incorporated, Halyard Health, Inc., TELEFLEX MEDICAL and Epimed International
Non-stimulating catheter segment by product is expected to dominate the market during the forecast period.
Stimulating Catheter (Open Tip Catheter Stimulating Catheter and Closed Tip Catheter Stimulating Catheter), Non-Stimulating Catheter (Open Tip Catheter Non-Stimulating Catheter and Closed Tip Catheter Non-Stimulating Catheter) and Over-The-Needle Catheter
Nerve Stimulation Based Insertion and Ultrasound Based Insertion
Trauma Cases, Upper Extremity Surgeries, Lower extremity Surgeries, Pain Management and Other Indications
Hospitals, and Ambulatory Surgical Centers
North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East & Africa
Continuous Peripheral Nerve Block Catheter Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
